Treatment of Thrombocytopenia secondary to chemotherapy – MCQ

Which of the following agents is used for the treatment of Thrombocytopenia secondary to myelosuppressive cancer chemotherapy?
A. Filgrastim
B. Sargramostim
C. Oprelvekin
D. Erythropoietin

Correct answer : C. Oprelvekin

Oprelvekin (Interleukin 11) is the only agent approved by the FDA for treatment of thrombocytopenia secondary to myelosuppressive cancer chemotherapy
Filgrastim (G-CSF) and Sargramostim (GM-SCF) are used in the treatment of neutropenia
Erythropoietin is used in treatment of anemia

PG Blazer is aimed at helping undergraduate medical students in acquiring more knowledge and increasing their chance of getting admission to postgraduate courses by performing well in the post graduate medical entrance examinations. Students are requested verify the accuracy of information in standard text books. This site is not meant for any medical advice or treatment. Please contact your physician for medical advice and treatment.

Related Posts